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Mammalian skin serves a number of vital physi-ological functions to maintain homeostasis.Skin provides a moisture barrier, regulates
body temperature via hair follicles, sweat glands, and
dermal capillaries, and provides lubrication via seba-
ceous glands. The functional properties of skin are of-
ten under-appreciated until substantial loss of the skin
occurs. In adults, the normal outcome of repair of mas-
sive full-thickness burns is fibrosis and scarring with-
out any appendages including hair follicles, sweat and
sebaceous glands. To date, no effective therapies have
been developed to prevent or reverse the fibrosis and
scarring which are different from the original skin in ap-
pearance and function. Studies are made to evaluate
the prospects of using stem cells for skin repair and
regeneration.
Stem cells are found in embryonic and adult tissues,
named independently embryonic stem cells (ESCs) and
adult stem cet deep into the dermal layer such as mes-
enchymal stem cells (MSCs), hematopoietic stem cells
(HSCs), epithelial stem cells, and neural stem cells.
These stem cells are defined by their capacity of self-
renewal and multilineage differentiation (Fig. 1). For
example, ESCs can give rise to cells of the three em-
bryonic germ layers: endoderm, mesoderm and
ectoderm.1, 2 Similarly, MSCs and HSCs derived from
bone marrow have the potential of differentiation into a
variety of tissues, including endothelium, liver, muscle,
bone, and skin. In addition, skin stem cells, including
epidermal stem cells and dermal stem cells, are also
multipotential. It is thought that they not only contrib-
ute to the production of their original tissues,3, 4 but also
can be stimulated into other cell types such as nerval
and osteogenic lineages.5-6 Because of the great differ-
entiation potential, stem cells have been thought to be
a powerful tool for treatment of a wide spectrum of dis-
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eases that are ineffectively treated by traditional
approaches. In this review, we present an overview of
the most recent advances in skin repair and regenera-
tion by using stem cells.
Skin repair and regeneration after injury
Re-epithelialization    Adult skin consists of two
tissue layers: a keratinized stratified epidermis and an
underlying thick layer of collagen-rich dermal connec-
tive tissues providing support and nourishment.
Appendages, such as hair and glands, are derived from
and linked to the epidermis but deep into the dermal
layer (Fig. 2). Cutaneous wound repair is a multifac-
eted process involving clot formation, cell migration,
extracellular matrix synthesis and deposition, and finally,
dermal and epidermal reconstitution. During this
process, the restoration of an intact epidermal barrier
through wound epithelialization, also known as re-
epithelialization, is an essential feature. Re-epithelial-
ization of a wound primarily involves the migration of
keratinocytes from the edges of the wound and hair
follicles to an extracellular matrix, their proliferation,
differentiation and stratif ication to form the neo-
epithelium. Recent evidences from an organotypic model
of wound healing in which keratinocytes were geneti-
cally labeled with retroviruses suggest that not only basal
cells migrate toward wounds but also suprabasal cells
may “leapfrog” over the basal cells.7 Once the denuded
wound surface has been covered by a monolayer of
keratinocytes, epidermal migration ceases and a new
stratified epidermis with underlying basal lamina is re-
established from the margins of the wound. But the
above natural repair process is slower compared with
the need for rapid wound cover to reduce infection rates
and the formed epidermis is different from the normal
epidermis because the regenerated epidermis is thin-
ner and with fewer and flatter epidermal ridges.
 Regeneration of appendages   In adult skin, su-
perficial burns that destroy the interfollicular epidermis
but leave hair follicles intact are healed rapidly and effi-
ciently with the regeneration of epidermal appendages.
But if a skin wound is deeper than the level of hair bulbs
in the dermis so that no remnants of hair follicles remain,
the repairing epithelium does not regenerate hairs, and
the same is true for sweat and sebaceous glands lost
at the site of injury. During embryogenesis, fibroblasts
in the dermal connective tissues supply permissive and
instructive signals that govern the positions and types
of hairs and other cutaneous appendages that will be
differentiated from the overlying epidermis. Adult wound
epidermis fails to regenerate appendages, not only be-
cause it is unable to respond to appendage-inducing
signals, but also because it does not receive such sig-
nals from the underlying wound dermis. To date,
therefore, the regeneration of appendages, especially
sweat glands, is a hard nut to crack in skin regenera-
tion medicine.
Currently, researches on stem cells bring promise
to functional repair of skin after severe burn injury,
namely, complete regeneration of skin and its
appendages. Application of stem cells can accelerate
the re-epithelialization of skin wound and bring possi-
bility of skin appendage regeneration (Fig.3). In essence,
there are at least four different ways of using stem cells
for skin repair and regeneration: local stem cell induc-
tion such as epidermal stem cells, transplantation of
stem cells induced in vitro, combination of stem cell
therapy with gene therapy, and the use of stem cells in
tissue engineering protocols.
Epidermal stem cells and skin repair and regen-
eration
Significant advances have been made in identifying
and locating the stem cells that inhabit the skin includ-
ing epidermal stem cells (interfollicular and bulge stem
cells), dermal stem cells,8 sebaceous stem cells, hair
follicle stem cells, sweat gland stem cells, melanocyte
stem cells, MSCs, neural stem cells and endothelial
stem cells. Epidermal stem cells first attract much at-
tention because of their importance for cell and gene
therapy in skin diseases. In the 1990s, researchers
using3 H-thymidine to evaluate the label retention to lo-
cate the stem cells in murine haired epidermis discov-
ered that the majority of stem cells in the skin reside in
the ‘‘bulge’’ region of the hair follicle (named bulge stem
cells), with only a small fraction of stem cells residing
in the basal layer of the interfollicular epidermis (named
interfollicular stem cells). These stem cells ensure the
maintenance of adult skin homeostasis and hair
regeneration, but they also participate in the repair and
regeneration of the epidermis after injuries.9
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Epidermal stem cells and re-epithelialization
(1) Induction of epidermal stem cells in situ    Epi-
dermal stem cells are generally thought to be the key
source not only for development of epidermis but also
for re-epithelialization of skin wound. Many factors, in-
cluding cellular mediators, cytokines, and growth
factors, induce and regulate the migration, proliferation
and differentiation of local epidermal stem cells, which
facilitate the repair and regeneration of skin after injury.
El Ghalbzouri et al.10 introduced a full-thickness wound
in human skin equivalents (HSE) made with a scalpel,
frozen by liquid nitrogen, and closed in the absence or
presence of exogenous growth factors. Then the rate of
re-epithelialization was monitored. The results obtained
in this study demonstrate that the re-epithelialization
process in full-thickness is accelerated by the pres-
ence of keratinocyte growth factor (KGF) and especial-
ly by epidermal growth factor (EGF), which support the
migration and proliferation of keratinocytes. Intriguingly,
the succedent research indicated that EGF promoted
the motility of individual cell and monolayer wound
closure, which was independent on an increase in cell
number.11 In addition, it’s worthy of notice that when leg
ulcers are treated with recombinant human epidermal
growth factor (rhEGF), there are some stem cells or
stem cells-like cells in the spinous and granular layers
of regenerated epidermis and these cells bear no ana-
tomic relation with the epidermal stem cells in the basal
layer.12-14 Therefore, it is possible that these undifferen-
tiated cells come from the differentiated cells through
dedifferentiation. Besides exogenous growth factors,
recent reports proved that endogenous cytokines and
growth factors secreted by local keratinocytes also have
an important role in re-epithelialization of skin wounds.
Simon et al.15 addressed that the altered cytokines and
growth factor expression in the wound resulted in the ac-
tivation of follicular and epidermal progenitor keratinocytes,
and ultimately mediated epidermal repair. From above
researches, we conclude that growth factors, which may
include KGF, EGF, TGF, bFGF, IL-6 and IL-1, play impor-
tant roles in promoting re-epithelialization by inducing
migration, proliferation, and differentiation of epidermal
stem cells in situ.
(2) Tissue engineering   Tissue engineering com-
bines the principles of cell biology, engineering and
material science to develop three-dimensional tissues
in replacing or restoring tissue function. Skin tissue
engineering emerges as an experimental regenerative
therapy motivated primarily by the critical need for early
permanent coverage of extensive burn injuries in pa-
tients with insufficient sources of autologous skin for
grafting. Today, the most commonly used skin grafting
technique employs the use of split-thickness grafts
taken from unaffected skin. This method is effective,
but it is limited by the available surface area of unaf-
fected skin and creates some degrees of additional
injuries. The technique of obtaining human skin with
dermis and epidermis reconstructed from cells isolated
from patients can enable autologous skin grafting in
patients with few donor sites.16 Indeed, the proliferative
Fig.1. A schematic diagram showing the plasticity of epidermal
stem cells, dermal stem cells, MSCs and ESCs in regenerative
medicine.
Fig.2. A schematic diagram of structure of skin. Location of epi-
dermal stem cells including interfollicular stem cells (1) and bulge
stem cells (2), dermal stem cells including dermal sheath stem
cells (3) and dermal papillae stem cells (4).
Fig.3. A schematic diagram of perfect skin regeneration by stem
cells including epidermal stem cells, dermal stem cells, MSCs and
ESCs.
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capacity of just a small patch of adult skin is immense
and the use of cultured keratinocytes allows a much
greater surface to be covered. The initial clinical use of
cultured keratinocytes is to create confluent epithelial
sheets that can be gently removed from the culture dish
and applied to reconstitute the epithelial portion of burns,
chronic wounds, and ulcers.17 At present, the use of
cultured keratinocytes is limited by the length of time
needed to grow epithelial sheets in vitro, during which
time the patient is susceptible to infection. The epithe-
lial sheets are also extremely fragile and do not adhere
well to some burned surfaces. Skin substitutes that
can function as dermal equivalents can hold the ex-
panding keratinocytes, improve adhesiveness to the
burn wound, and form a temporary wound cover to re-
duce infection rates.18, 19 By seeding large-scale cul-
tured epidermal stem cells onto a fibroblast-containing
dermal substrate, tissue engineered skin (TES) com-
posed of associated dermis and epidermis can be re-
constructed in vitro.20 The constructed TES is similar
to the uninjured skin in morphological features and can
satisfy the need of restoration of skin defects, yet it
lacks several important functions including those pro-
vided by hair follicles, sebaceous glands, sweat glands
and dendritic cells.
(3) Gene therapy    Gene therapy has been de-
scribed as a promising approach for treatment of skin
diseases21 and impaired wound healing22 and cultured
epidermal stem cells are used as delivery instruments
for gene therapy23. Researchers had devised methods
to use cultured human keratinocytes to correct inborn
metabolic skin diseases.24, 25 Keratinocytes were har-
vested from patients with recessive dystrophic epider-
molysis bullosa, and the genetic defect was corrected
either by genomic integration of the correct sequence
using a bacteriophage integrase or by transgene ex-
pression using a lentivirus. The repaired keratinocytes
were expanded in culture and grafted onto nude mice
to produce healthy epithelia in which the defect was
repaired. Although no study included grafting back onto
the original patient suffering from skin diseases, these
efforts represented a major advance toward the possi-
bility of manipulating stem cells to treat human
diseases. In the succedent research, epidermal stem
cells were used to prepare genetically corrected and
cultured epidermal grafts and were transplanted onto
the surgically-prepared regions of the patient’s legs.
The results indicated that the regenerated epidermis
was maintained by a defined repertoire of transduced
stem cells.26 In addition, gene therapy can also be used
in wound healing to promote tissue regeneration, espe-
cially being combined with tissue engineering. Wound
healing factors, such as platelet-derived growth factor
(PDGF)27 and vascular endothelial growth factor (VEGF)28,
can be transferred into epidermal stem cells that make
up the skin tissues. Therefore, gene therapy has the
potential to generate the next generation of three-di-
mensional skin substitutes with enhanced capacity for
treatment of burns, chronic wounds and even systemic
diseases.29, 30
Epidermal stem cells and regeneration of skin
appendages    Epidermal stem cells are the major
resource of the epidermis and skin appendages such
as hair follicles, sebaceous glands and sweat glands.
At present, we know that when interfollicular epidermis
is lost after injury hair follicle keratinocytes can repopu-
late the interfollicular epidermis and, conversely,
interfollicular keratinocytes grafted into an empty hair
follicle can produce normal hair. Hair cyclic regenera-
tion by activation of hair stem cells located in the fol-
licle bulge is regulated by Wnt/b-catenin, bone mor-
phogenetic protein 2 (BMP-2) and BMP-4.31, 32 But after
injury, the nascent hair follicles arise from epithelial cells
outside the stem cell niche of hair follicles, suggesting
that epidermal cells in the wound assume a hair follicle
stem cell phenotype. Further research shows that inhi-
bition of Wnt signalling abrogates this wounding-induced
folliculogenesis, whereas overexpression of Wnt ligand
in the epidermis increases the number of regenerated
hair follicles.33 It is likely that epidermal stem cells give
rise to sweat glands.34 In view of the relationship be-
tween epidermal stem cells and sweat gland cell
development, Fu et al.35-36 ventured to suggest that there
is a possibility to induce epidermal stem cells to di-
rectly differentiate into sweat gland cells and to estab-
lish a three-dimensional organization. Shikiji et al37 at-
tempted to regenerate eccrine sweat glands in vitro by
inducing the keratinocytes which were derived from
young donors. They first provided the evidence that re-
constructed epithelia of skin equivalents invaded into
a fibroblast-populated collagen gel and organized duct-
like structures that resembled eccrine sweat ducts in
the presence of EGF and FBS in vitro. These results
indicate that some of the postnatal keratinocytes from
young donors still possess pluripotent ability to be dif-
ferentiated into eccrine sweat ducts/glands in response
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to EGF and FBS. Although it is not a perfect model,
this research provides hope that functional skin equipped
with eccrine sweat glands can be generated in vitro for
autologus transplantation in cases of extensive burns,
for example.
Dermal stem cells and skin repair and regenera-
tion
Hair follicle dermal stem cells    Mammalian der-
mis contains a multipotent precursor cell population.
These cells termed skin-derived precursors (SKPs) were
isolated and expanded from rodent and human skin.38
In recent years, it has become evident that the hair
follicle represents an important stem cell niche in the
skin. Hair follicle dermal stem cells reside in the der-
mal papillae (DP) at the base of the follicle and the
dermal sheath (DS) that surrounds the outside of the
hair follicle.8, 39 These cells exhibit some properties of
stem cells, including regenerative potential,5, 39, 40 roles
in wound healing and ability to produce a functional
dermis. DP cells, which are the major components of a
hair DP, produce and secrete several growth factors,
molecules constructing extracellular matrix components,
and cytokines such as basic fibroblast growth factor
(bFGF), endothelin-1 (ET-1), stem cell factor (SCF), and
so on.41-43 So they are generally thought to play essen-
tial roles in the induction of new hair follicles and the
maintenance of hair growth.44, 45 DS cells can be trans-
formed into DP cells under the influence of follicle ger-
minative epithelium. If the base of a follicle is removed
experimentally, the lower follicle dermal sheath (LDS)
cells can replace the dermal papilla cells and restore
functional hair growth. Similarly, DS cells can also be
incorporated into dermal repair in a manner similar to
skin fibroblasts, which results in qualitatively improved
dermal repair.46 Intriguingly, DS cells from the base and
the upper follicle behave differently during this repair
process: only the LDS cells are incorporated into fol-
licle and interfollicular dermis.47 In addition, there are
many experiments about hair follicle induction in heal-
ing wounds by follicle dermal stem cells. Although DP
cells do not induce the reformation of hair follicle struc-
ture in vitro due to some reasons such as that they
cannot aggregate and reform the cell clump, that they
successfully induce many hair follicles as well as the
reformation of hair fibres when they are transplanted
into the nude mice and that the reformed hair can be
observed by naked eyes.48 However, the number of re-
generated hair follicles in above experiments is limited.
So the remaining problem is how to enhance the fol-
licle-inducing effects of follicle dermal stem cells. Osada
et al.49 aggregated the DP cells to form spheres and
then injected them with epidermal cells. Unlike the dis-
sociated DP cells, the spheres induced more new hair
follicles. These results suggest that sphere formation
partially models the intact DP, resulting in hair follicle
induction. Moreover, the cell combination of intact pa-
pillae together with DS and outer root sheath (ORS)
cell cultures can produce new follicles in wound sites
and these follicles have sebaceous glands and are ori-
ented in an irregular fashion.47 Therefore, whether cul-
tured DP cells induce follicle formation appears to
depend, at least partly, on environmental criteria. Up to
now, tissue-engineered skin equivalents have several
deficiencies, including the absence of hair follicles. In
some reports, the reformation of follicle-like structure
is successfully induced in vitro by DP or DS cells in a
three-dimensional mixture culture. Wu et al.50 observed
that hair follicle-like structure could be reformed in der-
mal sheath cell-populated collagen gel when combined
with superior or inferior epithelial cells by organotypic
(three-dimensional) culture. Therefore, we believe that
the application of follicle dermal stem cells in the field
of cell transplantation and tissue engineering will pos-
sibly achieve the hairy healing of the wound.
Non-follicle dermal stem cells    Various cell
populations can be obtained from dermis with different
culture systems. Recently, Bartsch et al.51 have iso-
lated another multipotent cell population, termed der-
mal MSCs, from low-temperature preserved human fore-
skin biopsies with adherent culture. The isolated cells
can be expanded for over 100 population doublings with
retention of their chromosomal complement and
multipotency. They reported that a single dermal MSC
could differentiate into adipogenic, osteogenic and
myogenic lineages. In addition, Perng et al.52 reported
that human dermis-derived MSCs (hDMSCs) possess
differentiation potential of epidermis facilitating wound
healing in skin-defect nude mice and the re-epithelial-
ization marker of human pan-cytokeratin is significantly
increased on day 14 and day 21 in the wound site of
hDMSCs and gelatin/pNIPAAm/PP-treated group.
Recently, multipotent fibroblasts expressing nestin- and
vimentin+ were also isolated from human dermis.53 Der-
mal fibroblasts are commonly accepted as terminally
differentiated cells, which are routinely used as a nega-
tive control for evaluation of cell multipotency in many
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studies.54 Yet, the researchers found that dermal fibro-
blasts isolated from human foreskin could differentiate
into adipogenic, osteogenic or chondrogenic lineages
in the presence of certain factors, suggesting that der-
mal fibroblasts might contain a pluripotent subpopulation.
The relationship between multipotent dermal fibroblasts
and dermal MSCs remains unclear and deserves fur-
ther investigation. However, multipotent cells may also
exist in other non-follicle zones of the dermis. Multipotent
cells have been identified from marrow stroma and adi-
pose tissues, which have a similar mesodermal origin
from embryonic development with dermis.55, 56 Although
the potential physiological role of the non-follicle stem
cells in dermis is unclear, the multipotency of these
cells suggests that they might be a useful cell source
for therapeutic purposes.
MSCs and skin repair and regeneration
MSCs are non-hematopoietic cells, which were first
described by Fridenshtein et al.57 in 1986 as the clonal
and plastic adherent cells, being a source of osteoblastic,
adipogenic and chondrogenic cell lines. The main source
of MSCs is bone marrow. These cells constitute,
however, only a small percentage of the total number of
bone marrow populating cells. Apart from the bone
marrow, MSCs are also located in other tissues of the
human body. There is an increasing number of reports
describing their presence in adipose tissues, umbilical cord
blood, chorionic villi of the placenta,58 amniotic fluid,59
peripheral blood, fetal liver,60 lungs,61 and even in
exfoliated deciduous teeth62. Human MSCs are known
to constitute a heterogeneous population of cells. The
culture of MSCs demonstrated that single-cell-derived
colonies of human MSCs contain three morphologically
distinct kinds of cells including spindle-shaped cells, large
cuboidal or flattened cells and extremely small cells that
are rapidly self-renewing (RS cells). The RS cells appear
to be the earliest progenitors in the culture and have the
greatest potential for multilineage differentiation.
MSCs and re-epithelialization    Because they
can be obtained easily, MSCs derived from bone mar-
row have received considerable attention. It has shown
that a single bone marrow-derived stem cell is able to
differentiate into epithelial cells of the liver, lungs, gas-
trointestinal tract, and skin.63 Systemic transplantation
and local implantation of MSCs are promising treatment
methods for skin wounds,64 especially for chronic wounds65, 66.
Badiavas et al.67 obtained bone marrow from green fluo-
rescent protein (GFP)-expressing transgenic mice and
then gave it to the recipient (non-GFP expressing) mice
by tail vein injection. At last, they found that GFP-la-
beled cells differentiated into non-hematopoietic skin
structures in wounded skin, implying that the trans-
planted MSCs have the ability to migrate to the dam-
aged tissue sites and stimulate repairs by differentiating
into skin-specific cells. In addition, experiments of influ-
ence of local application of MSCs on cutaneous wound
regeneration showed that GFP-labeled MSCs could con-
vert into the phenotypes of epidermal keratinocytes, se-
baceous glands, follicular epithelial cells, and vascular
endothelial cells by transdifferentiation.68-71 Wu et al.72
also proved that bone marrow derived MSCs-treated
wounds exhibited significantly accelerated wound clo-
sure with increased re-epithelialization, cellularity and
angiogenesis. In a human study of chronic nonhealing
wounds, the results showed that direct application of
bone marrow-derived cells can lead to wound closure
and possible rebuilding of tissues.65 This study, although
interesting, was hampered by the lack of an efficient
delivery system for the autologous bone marrow-derived
cultured cells. More recently, Falanga et al.66 have ap-
plied human autologous bone marrow-derived cultured
cells to nonhealing and acute wounds, using a special-
ized fibrin spray system. This approach appears to be
safe and may represent a rather ideal way of introduc-
ing cells into injury sites.
Despite the accumulating data of skin lineage dif-
ferentiation from MSCs in vivo,73 studies on differentia-
tion of MSCs into epithelial lineage cells in vitro are
also performed74. Wu et al.75 proved that MSCs derived
from the early human embryo have the ability to trans-
form into epidermal cells in vivo and in vitro. Consistent
with this, hMSCs derived from adult bone marrow also
possess the potential of differentiating into epidermal-like
cells with the production of keratin 19, P63, and β1  -
integrin under certain conditions.76, 77 Recently, our group
reported that P38 route may play an active role in the
differentiation of MSCs into epidermoid cells because
enhancing the activation of P38 route by blocking the
upstream signal Rho can promote the differentiation of
MSCs into epidermoid cells.78 All experimental data
from above researches suggest that hMSCs have the
potential of epidermal differentiation under a specific
differentiation condition. But there are no experiments
in vivo to verify that the induced hMSCs are the same
as the epidermal cells. Therefore, we call them epider-
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mal-like cells. However, we believe that epidermal-like
cells differentiated from hMSCs can be used as a cell
source for tissue engineering and cell therapy.
Skin tissue engineering is a possible solution for
extensive skin defects. The ultimate goal of skin tissue
engineering is to restore the complete functions of native
skin, but until now the structure and function of skin are
only partially restored. Recently, the suitability of  hMSCs
for soft tissue engineering was investigated.79 These cells
were seeded onto 1-ethyl-3-3-dimethylaminopropyl
carbodiimide (EDC) cross-linked collagen sponges and
implanted in immunodeficient mice. After 2 and 6 weeks
in vivo, populated scaffolds showed a high density of
vascularization and cellularity. Perng et al.80 also dem-
onstrated that the hBMSCs possess the differentiation
potential of epidermis and the capability of healing skin
wounds by culturing adult hBMSCs on gelatin scaffolds
with poly N-isopropylacrylamide (pNIPAAm).
Interestingly, BMSCs can be used to construct full-
thickness tissue-engineered skin, because BMSCs
have the potential to differentiate into epidermal cells
and fibroblasts in vitro and show clinical feasibility when
acting as epidermis-like and dermis-like seed cells in
skin engineering.81
MSCs and regeneration of skin appendages   In
addition to transdifferentiation to epidermal-like cells in vitro
and promotion of wound repair in vivo, regeneration of skin
appendages may be another potential application of MSCs
in regenerative medicine. The experiments of systemic trans-
plantation and local implantation of MSCs for cutaneous
wound regeneration demonstrate that the MSCs migrating
into the wound sites can promote the repair and regenera-
tion of skin wounds by transdifferentiation into phenotypes
of epidermal keratinocytes, sebaceous glands, and fol-
licular epithelial cells.68-70 Wu et al.72 transplanted GFP+
BM-MSCs into wound healing model and determined
the contribution of BM-MSCs in dermal keratinocytes
and appendages. They found that some BM-MSCs
positive for GFP and cytokeratin in the dermis of the
wounded skin formed structures resembling  develop-
ing sweat or sebaceous glands. In another research,
porcine MSCs were isolated and engrafted into porcine
skin. Results showed that transplanted MSCs lablled
with BrdU were transdifferentiated into sebaceous duct
cells.82 Consistant with above results, we found that
BrdU-labelled MSCs, which were collected from Wistar
rats and infused from the penile vein, emerged in the
hypodermia, the sebaceous glands, and the hair fol-
licles of the wounds on the midback of the homoge-
neous male Wistar rats.83 Investigation into the mecha-
nism of the transdifferentiation shows that the wound
microenvironment containing diverse growth factors or
inflammatory factors may play an important role in this
process. Among the skin appendages, sweat glands are
most important because they possess the functions of
temperature regulation and homeostasis maintenance.
But they cannot be regenerated in full-thickness burn
wounds via remnants of skin tissues.35, 36 The recruit-
ment of MSCs to skin wounds and the participation of
MSCs in cutaneous repair imply that MSCs may play a
potential role in sweat gland regeneration.84 Despite the
fact that the regeneration of sweat glands is a difficult
and perplexing problem, we make an effort to explore
the possibility of transdifferentiation of stem cells into
sweat gland cells in vitro.85, 86 In our experiment, adult
MSCs were co-cultured directly or indirectly with heat-
shocked sweat gland cells and the phenotypes of the
co-cultured cells were examined. The results showed
that 4% of the BrdU+ MSCs added to the co-cultures
were differentiated into sweat gland cells, which expressed
the proteins of sweat gland cells: carcinoembryonic anti-
gen (CEA) and cytokeratin 19, markers of the gland cells.
In addition, the percentage of differentiation was enhanced
by epidermal growth factor and the injured
microenviroment.87, 88 Further researches showed that
the extracellular signal-regulated kinase (ERK) pathway,
especially pERK, was involved in the phenotype conver-
sion of human MSCs into human sweat gland cells.87, 89
There are two possible mechanisms for the conversion
of MSCs into other mature non-hematopoietic cells of
multiple tissues: transdifferentiation and cell fusion.
Transdifferentiation refers to the conversion of one cellu-
lar phenotype to another by changing the expression of
a master regulatory (master switch) gene, whose nor-
mal function is to distinguish the two tissues in normal
development and belongs to a wider class of cell-type
switches termed metaplasias. Cell fusion means that
stem cells or their progeny fuse with cells of other types,
mixing cytoplasmic and even genetic materials of dif-
ferent (heterotypic) origins, thereby converting the gene
expression pattern of stem cells to that of the fusion
partner. However, which path should answer for the
phenotype conversion of human MSCs into human
sweat gland cells needs to be further investigated.
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ESCs and skin repair and regeneration
 Derivation of ESCs from reprogrammed human
skin cells    ESCs were first established from the inner
cell mass (ICM) of mouse blastocysts in 1981,90 and
human ESCs were first derived in 199891. However, the
use of human embryos faces ethical controversies that
hinder the application of human ESCs. In addition, it is
difficult to generate patient- or disease-specific ESCs,
which are required for their effective application. One
way to circumvent these issues is to induce pluripotent
status in somatic cells by direct reprogramming. So-
matic cells can be reprogrammed to an embryonic-like
state by injection of nucleus into enucleated oocyte92-95
or by fusion with ESCs96, 97. Researchers reported the
use of nuclei from hair follicle stem cells and other skin
keratinocytes as nuclear transfer (NT) donors to clone
mice, revealing skin as a source of readily accessible
stem cells. And the nuclei of stem cells can be repro-
grammed to the pluripotent state by exposure to the
cytoplasm of unfertilized oocytes. In primates, the re-
sults of somatic cell nuclear transfer (SCNT) are char-
acterized with inefficient reprogramming and poor em-
bryonic development. Byrne et al.98 used modified SCNT
approach to produce rhesus macaque blastocysts from
adult skin fibroblasts, and successfully isolated two ESCs
lines from these embryos. The discovery that nuclei
from mammalian differentiated cells can be repro-
grammed to an undifferentiated state by transacting
factors present in the oocytes leads to a search for
factors that can mediate similar reprogramming with-
out SCNT. Recently, four transcription factors (Oct4,
Sox2, c-myc, and Klf4) were shown to be sufficient to
reprogramme mouse fibroblasts to undifferentiated,
pluripotent stem cells [termed induced pluripotent stem
(iPS) cells].99-103 Moreover, researchers  have repro-
grammed adult human dermal fibroblasts into so-called
iPS cells with the same four factors and the human iPS
cells were similar to human ESCs in morphology,
proliferation, surface antigens, gene expression, epige-
netic status of pluripotent cell-specific genes, and
telomerase activity.104,105 Lowry et al.106 also acquired
the same result by ectopic expression of the same set
of four genes with the addition of the NANOG transcrip-
tion factor in dermal fibroblasts. At the same time, Yu
et al.107 also successfully reprogrammed human so-
matic cells into iPS cells that exhibited the essential
characteristics of ESCs with four candidate reprogram-
ming genes: OCT3 and SOX2, as Takahashi et al.104
used, and two different genes, NANOG and LIN28.
Nakagawa et al.108 generated human iPS cells from adult
dermal fibroblasts without c-Myc. Furthermore, the thera-
peutic potential of such iPS cells were investigated by
using a humanized sickle cell anemia mouse model.109
However, the human iPS cells are not identical to hu-
man ESCs. So further studies are essential to deter-
mine whether human iPS cells can replace human
ESCs in medical applications.
ESCs and wound repair   ESCs can be induced
in vitro to differentiate into cutaneous cells, which can
be applied to bioengineered skin to facilitate the wound
repair and regeneration.110 During embryonic
development, skin forms as a result of reciprocal inter-
actions between mesoderm and ectoderm. Epithelial
cell differentiation from ESCs can be identified by the
presence of cytokeratin intermediate filaments and
keratinocyte-specific involucrin.111, 112 After in vitro differ-
entiation of mouse embryonic stem (mES) cells, en-
richment of keratinocytes and seeding onto various
extracellular matrix (ECM) proteins in the presence of
BMP-4 and/or ascorbate can promote the formation of
epidermal equivalents, which are composed of strati-
fied epithelium (when cultured at the air-liquid interface
on a collagen-coated acellular substratum). The resulted
tissues display morphological patterns similar to nor-
mal embryonic skin. The cells express late differentia-
tion markers of epidermis and markers of fibroblasts,
which are consistent with those found in native skin.
The data suggest that ESCs have the capacity to re-
constitute in vitro fully differentiated skin.113 In another
report, Troy et al.114 developed a two-step culture
scheme in which pluripotent mouse ESCs were induced
first to a surface ectoderm phenotype and then posi-
tively selected for putative epidermal stem cells. It
showed that the earliest stage of epidermal develop-
ment followed an ordered sequence that was similar to
that observed in vivo (expression of Keratin 8, Keratin
19, Keratin 17, and Keratin 14). To date, however, the
molecular mechanisms controlling epidermal commit-
ment of ESCs are unclear. Further researches showed
that p63 and BMP-4, which play pivotal roles in ecto-
dermal and epidermal development, may be involved in
this process.115
Other stem cells and skin repair and regeneration
Besides epidermal stem cells, marrow-derived stem
cells and ESCs, other stem cells derived from adult
tissues may also serve as cell therapy to enhance the
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healing process in skin wounds. Muscle-derived stem
cells obtained from the muscle of New Zealand white
rabbits were cultured in vitro for two weeks and then
seeded onto a circular 2-cm-diameter defect created
on the dorsal side of the ear of the rabbit. Fourteen
days later, re-epithelialized areas were significantly greater
in the treatment group, but the wounds in the control group
showed nonepithelialized areas.116 Interestingly, there is
another report that the sweat apparatus is capable of
re-epithelializing the skin surface after a major cutane-
ous wound.117 These data suggest that the use of au-
tologous stem cells in skin wounds expedites and im-
proves the organism’s natural healing process.
Conclusion
In spite of recent advances from breakthroughs in
recombinant growth factors and bioengineered skin,
perfect skin regeneration remains a formidable chal-
lenge because of fibrosis and scarring without any ap-
pendages after full-thickness burns. Stem cells offer
the possibility that some structures within the wound,
such as epidermis, hair follicles, sebaceous glands and
sweat glands, may be reconstituted. To what extent
that it comes true remains uncertain and much work
needs to be done before clinical application of a stem
cell-based therapeutic approach in perfect skin
regeneration. Firstly, we should explore more and more
stem cells to solve the limited resource of stem cells.
At present, there are three major ways by which scien-
tists can acquire stem cells including direct isolation
from embryonic and adult tissues, dedifferentiation from
some differentiated cell types, and transdifferentiation
from other cellular phenotypes. But all above methods
are still not enough to provide sufficient source of stem
cells for regenerative medicine. Secondly, despite re-
cent progress in the lab and in clinic, there are still
many gaps in our understandings of basic stem cell
biology that must be addressed before stem cell
therapy can be applied to its fullest potential in clinic.
Therefore, if we can understand what regulates the fate
of stem cells, we can potentially enhance the function
of the graft, avoid potentially deleterious genes, and
select target-specific differentiation pathways that lead
to the formation of sebaceous and sweat glands, hair
follicles, and interfollicular epidermis. Thirdly, three-di-
mensional reconstruction of appendages by using stem
cells, such as sweat glands, has long been considered
as a much greater challenge. Thus far, a few studies
have offered some evidences that stem cells may play
a potential role in sweat gland regeneration. But there
is no report that intact sweat glands including secre-
tion and duct sections are regenerated in vivo or in vitro
by using stem cells. In conclusion, there is still a long
way to go before we realize the full potential of stem
cells in regenerative medicine. But with our great ex-
perimental efforts, the vision of perfect skin regenera-
tion with stem cells will come true in the future.
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